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CFTR is involved in the ion/water contents and exocytosis of airway 
glandular secretory granules 
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We have previously shown (Baconnais et aI, 2CO4) that in airway submucosal 
serous glands, CFFR is present at the membrane of intracytoplasmic secretory 
granules and that in CF airway cells, there is a decreased water and abnormal ion 
content associated with defective xccytosis. This suggests that in CF, the loss of 
CFTR may be involved in the dehydration of mucus and deficient exccytosis. In 
order to confirm this hypothesis, we  analyzed the direct implication f CFFR on the 
ion, water content and exccytosis prccess of CF and non CF airway secretory 
granules, using either a specific inhibitor of CFTR (CFFR a 172) or after 
transducing CF cells with a lentiviral vector encoding the CFFR cDNA (Castillon 
et aI, 2CO4). Ion and water content were measured on freeze<lried cryosections by 
electron probe X ray micro analysis and dark field imaging, respectively. The 
exccytosis of secretory granules was analyzed by phase~contrast videomicroscopy 
and the chloride secretion was measured by fluorescence microscopy (SPQ probe). 
We observed in CF cells that the forskolin stimulated CI secretion, ion, water 
content and exccytosis were restored after lentiviral  vector CFFR cDNA 
transduction. Fol lowing the incubation of non CF cells with CFFR inhibitor, we  
observed a significant decrease in the forskolin stimulated CI secretion and a 
decrease in the exccytosis of secretory granules. Our data provide strong evidence 
that, in the airway glands, the secretory granules are CFFR dependent and support 
the concept that in CF, inadequate hydration of secretory granules may induce a 
defective glandular secretion and could play an active role in the early decrease of 
mucccil iary clearance. 
Supported by INSERM, Association "Vaincre la Mucoviscidose" and 
GlaxoS mithKline. 
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Discovery of a new agent able to correct cystic fibrosis defect 
C. Norez, C. Vandebr ouck, F. Becq 
IPBC, Poitiers, Fratwe 
Phenylalanine deletion in position 508 cause defective trafficking of CFTR (cystic 
fibrosis transmembr ane conductance regulator) channels to the plasma membrane. 
To identify compounds able to correct he abnormal trafficking delF508 CFTR, we  
have developed an automatic assay based on the iodide eff lux measurement from 
the human airway epithelial CF cell l ine JME/CF 15. 
Here we present results showing the identification of a novel agent able to restore 
the trafficking of delF508 CFTR protein. The compound CFFR T1, discovered by 
our screening, corrects CF defect with an ECs0 of 56 pM. Immunoprecipitation, 
western blot and confccal immunofluorescence analysis show the restoration of a 
mature delF508 CFFR at the cell surface. To investigate the molecular mechanism 
of CFFR T1, we  realized competition studies between CFFR T1 and inhibitors of 
the ER chaperone machinery. No potentiation occurs after treatment with CFFR T1 
and compounds that inhibit degradation. A small potentiation is obtained after 
treatment with CFFR T1 and agents that inhibit interaction between CFFR and 
calnexin, a Ca 9+ dependant ER membrane chaperone. Additional studies how that 
CFTR T1 stimulates intracellular Ca 9+ increase, consecutive of the ER emptying. 
Moreover a partial inhibition of CFFR T1 effect is observed in presence of 2 APB, 
an IP3 receptor inhibitor. 
We conclude from the present study that CFTR T 1 restores the abnormal trafficking 
of delF508 CFFR via Ca 9+ dependent and Ca 9+ independent mechanisms of action. 
We hypothesize that CFTR T 1 treatment of CF cells interferes with the ability of the 
ER quality control machinery to interact and to retain delF508 CFFR proteins into 
the ER through the hlhibition of calnexin or/and molecular chaperones of the 
degradation pathway. 
Supported by CF Pronet, VLM and CNRS. 
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The two conserved glycine within the ABe signature sequence of 
CFTR control the inhibition and activation of the chloride channel 
activity 
P. Mel in,  C. Norez, F. Becq 
IPBC, UMR6187 Universitd e Poitiers, Poitiem, France 
The isoflavone Genistein (Gst) acts on CFTR with 2 different binding sites, with 
opposite effects, involving the two c nserved Glycine of ABC signature, the G551 
and G1349 (Mel in et aI., 2CO4). The action of Gst is refelred as non Michaelis 
Menten behavior with a typical biphasic response : low concentrations activate 
CFTR whereas higher concentrations inhibit it. We have now examined the 
behavior of CFTR wiM type and several CF mutants in presence of PhloxineB 
(PhlxB), a fluorescein derivative known to modulate CFTR activity by direct 
interactions with iodide eff iux and patch~clamp techniques. CFTR wt channel 
activity is stimulated by PhlxB at concentration ranging from 0.1 to 10 pM and 
inhibited at concentration above 10 ~tM. Interestingly, similar bel l  shaped 
pharmacological profi le is obtained with CFTR F508del, which membrane 
pr ccessing is restored by exposure at 27°C during 24h. By contrast, CFFR G551D, 
mutated within the signature sequence LSGGQ of NBD1,  is activated by PhlxB but 
not inhibited at high concentrations (EC>0 2.05 + 1.13 pM). Moreover, the 
activatable channel CFFR G1349D, with the analogous mutation in LSHGH 
sequence of NBD2,  is refractory to PhlxB stimulation even at very high 
concentration (300 pM). Our data demonstrate hat (1) the G551 is necessary for the 
inhibitory site of PhlxB on CFFR protein (2) the G1349 is required for the 
activatory site of PhlxB on CFFR (3) Gst and PhlxB have similar allosteric effects 
on CFTR chloride channel activity. This study underlines the opposite role of the 
two conserved Glycine in the activation and/or inhibi t ion of CFFR by 
pharmacological gents l ike Genistein and PhloxineB. 
Supported by Conseil R6gional du Poitou Charentes, CF Pr onet, CNRS and VLM 
IdenSfication of a potential casein kinase2 (CK2) site within the CBS2 
domain important for CIC-2 channel trafficking, expression and 
funcSon 
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Expression of the CIC 2 voltage gated chloride channel in epithel ia suggests a role 
for this channel in transepithelial C t transport. Recently, CIC 2 was demonstrated 
to serve as an exit pathway for CI in the basolateral membranes of the colon. On 
the other hand, localization of CIC 2 at the apical membrane of airway cells 
suggests that CIC 2 could represent an alternative pathway for impaired CI 
transport in CE At  the molecular level, CIC channels possess a long cytosolic C
terminus containing 2 CES domains. These domains have been suggested to play a 
role in channel trafficking and function. In this context, we studied the relevance of 
a threonine residue (T840) located within a consensus CK2 site in the CB $2 domain 
of CIC 2. Mutations T84OV and T84OE were obtained by site directed mut agenesis. 
Coding sequences were subcloned in pIPES EGFP and stably expressed in 
HEK293 cells. This model was used to study CIC 2 phosphorylation, expression 
and localization. Channel function was measured using the patch clamp technic. 
The results showed that WTCIC 2 can be phosphorylated in vitro by CK2. WTCIC 
2 lccalized at the plasma membrane and in intracellular compartments. Mutation 
T840V lowered channel expression and induced an intracellular retention of the 
protein. This mutation also induced a marked decrease of C t  currents associated 
with a shit) of the voltage dependence of current activation by 45mV. Introduction 
of a negative charge (T84OE) restored all WT characteristics, hahibition of CK2 
decreased WTCIC 2 but not T84OE expression. These results demonstrate a key role 
for a negative charge on residue 840 in agreement with CK2 phosphorylation of this 
residue for CIC 2 stability, traffic and function. 
